Although suppressed Bmal1 expression in PDAC has been suggested to modulate Trp53 to promote a tumor suppressor effect, this was unlikely the case in our study considering KPC cells are a Trp53-mutant cell line [20]. The gene discussed is TP53; the disease is neoplasm.